Blood Thinner Recalled

Rising Pharmaceuticals is recalling 12,216 bottles of warfarin sodium tablets, 1 mg, because samples failed to meet impurity/degradation specifications during routine testing, according to the March 1, 2023, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects 100-count bottles (NDC 57237-119-01) from batch NB101596 (Exp. 4/30/23). Rising Health, Saddle Brook, New Jersey, distributed the tablets to 16 distributors and eight wholesalers, who may have further distributed the product nationwide.

Rising Pharmaceuticals voluntarily initiated the recall February 15, 2023. The FDA designated the recall Class II on February 23, 2023, signaling use of the drug could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.

Warfarin is a prescription blood thinner used to treat and prevent blood clots.